Beijing Dabeinong Biotechnology Co., Ltd. (Dabeinong Biotechnology for short) is a member company under the Dabeinong Technology Group, founded in 2010. The company's mission is to develop an agricultural biotechnology industry with proprietary intellectual property rights, focusing on crop productivity, nutritional health, and sustainable development. It has now become one of the leading brand enterprises in China's modern agricultural industry, with significant brand influence and international competitive potential.

With the vision of becoming a "leading enterprise in agricultural biotechnology innovation" and adhering to the principles of "innovation-driven growth, global perspective, and shared development", Dabeinong Biotechnology focuses on the research and development of biotechnology for crops such as corn and soybeans. The company promotes the efficient transformation and application of innovative achievements in biological breeding, taking this as its core focus. Guided by market demand, Dabeinong Biotechnology extends its cooperation with the seed industry, agrochemicals, and other fields, becoming a significant force in promoting the industrialization of modern bio-agriculture in China. The company has established three major strengths: Leading technology, excellent products, and a professional platform, contributing to the high-quality development of modern agriculture in China.

To further enhance its compliance level and align its management with international standards, Dabeinong Biotechnology officially became a member of Excellence Through Stewardship (ETS) in 2012, making it one of the first Chinese member companies to conduct full-process traceable management of biological breeding R&D and market operations in accordance with the highest industry standards. The company's human resources advantage is the key to ensuring its R&D capabilities and technological leadership. The research team is led by an international management team, with more than 20 elite PhDs at its core and over 60 professional master's degree holders as key members. The team has an average age of 33, with a postgraduate ratio of nearly 67%, and is highly educated, young, and brimming with entrepreneurial spirit and innovative energy. As of mid-2023, the company has nearly 460 invention patent applications, more than 230 authorized patents, 22 registered copyrights, and other independent intellectual property rights, continuously generating R&D achievements and proprietary intellectual property. Dabeinong Biotechnology persists in promoting and leading the leap-forward development of China's biological breeding industry, forging a unique path for Chinese biotechnology enterprises to empower the high-quality development of agriculture.